Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of γ34.5-mediated virulence

R. Kanai, H. Tomita, A. Shinoda, M. Takahashi, S. Goldman, H. Okano, T. Kawase, T. Yazaki